Modulation of Epigenetic Targets for Anticancer Therapy: Clinicopathological Relevance, Structural Data and Drug Discovery Perspectives

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|4|578-613

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.4, 2013-02, pp. : 578-613

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epigenetic Therapy: Histone Acetylation, DNA Methylation and Anti-Cancer Drug Discovery

By  

Current Cancer Drug Targets, Vol. 9, Iss. 8, 2009-12 ,pp. : 963-981

Bentham Science Publishers

Access to resources Recommend Favorite

Current Targets for Anticancer Drug Discovery

By  

Current Drug Targets, Vol. 4, Iss. 2, 2003-02 ,pp. : 159-179

Bentham Science Publishers

Access to resources Recommend Favorite

Signal Transduction Pathway Targets for Anticancer Drug Discovery

By  

Current Pharmaceutical Design, Vol. 6, Iss. 4, 2000-03 ,pp. : 361-378

Bentham Science Publishers

Access to resources Recommend Favorite

Perspectives in Medicinal Chemistry: Metallomics and New Targets in Metal-Based Drug Discovery

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 29, 2016-12 ,pp. : 3381-3382

Bentham Science Publishers

Access to resources Recommend Favorite

Leveraging Cell Cycle Analysis in Anticancer Drug Discovery to Identify Novel Plasmodial Drug Targets

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 10, Iss. 3, 2010-01 ,pp. : 165-190

Bentham Science Publishers

Access to resources Recommend Favorite